Reports

Completion of the Company’s financing phase and conclusion of loan agreements

Concluding an agreement with a transaction advisor

Receipt of the decision on granting patent protection for the invention in the territory of Brazil

Commencement of review of strategic options and signing of contract to perform IP valuation of the company

Obtaining patent protection for an invention from the European Patent Office

Signing a commercial agreement for distribution of Genomtec®ID

Market authorisation for sales of Genomtec® ID

Signing a commercial agreement to sell Genomtec® ID

Commencement of comparative research

Receipt of the decision on granting patent protection from the European Patent Office

Start of pilot production of analysers Genomtec®ID in the UK

Acceleration of the Genomtec® ID platform commercialization and signing up loan agreements in connection to financing of the fast-tracked project activities

Patent filing application for a method of heat transfer and its measurement with the UK Intellectual Property Office (UK IPO)

Receipt of the decision on granting patent protection for the proprietary set of primers, diagnostic method, and the use of primer set for HPV infection detection to genetically diagnose HPV16 (Human papillomavirus type 16) in the territory of Republic of Poland

Planned acceleration of the Genomtec®ID platform commercialization process

Submission to the Financial Supervision Authority of an application for approval of the prospectus of Genomtec S.A.

Receipt of the decision on granting patent protection for the temperature control invention in the territory of Republic of Poland

Receipt of the decision on granting patent protection for the invention in the territory of Japan

Patent application filed for the proprietary set of primers, diagnostic method, and the reaction mixture composition to genetically diagnose Salmonella enterica infections in LAMP technique

TÜV Rheinland has issued ISO 13485 certificate for Genomtec

Patent filing application for the proprietary set of primers, diagnostic method and the reaction mixture composition to genetically diagnose Neisseria Meningitidis in LAMP technique

A contract signed with specialist clinical center based in Gliwice to execute part of the comparative study (referenced to the Real-Time RT-PCR method) validating the SARS-CoV-2 infection detection kit based on the saliva Direct-RT-LAMP technology

A contract signed with Cellgen Molecular Pathology Centre, Aurimed Private Healthcare Trust to execute part of the comparative study (referenced to the Real-Time RT-PCR method) validating the SARS-CoV-2 infection detection kit based on the saliva Direct-RT-LAMP technology

Market authorisation for sales of Genomtec® SARS-CoV-2 EvaGreen® Direct-RT-LAMP CE-IVD Kit

Patent protection has been granted for a set of primers for amplifying the nucleotide sequence of Borrelia burgdorferi, a method for detecting Borrelia burgdorferi, a method for diagnosing Lyme disease and a kit for diagnosing Lyme disease

Signatory of a cooperation agreement leading to opening of a diagnostic laboratory that utilizes Issuer’s products and know-how

Patent filing application for the proprietary set of primers, diagnostic method and the reaction mixture composition to genetically diagnose MRSA (methicillin-resistant staphylococcus aureus) in LAMP technique